Guardant Health
GH
#1184
Rank
โ‚น1.920 T
Marketcap
โ‚น14,484
Share price
-1.50%
Change (1 day)
267.56%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น303.54

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น327.32. In 2025 the company made an earnings per share (EPS) of -โ‚น319.60 an increase over its 2024 EPS that were of -โ‚น343.74.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น303.54-5.02%
2025-โ‚น319.60-7.02%
2024-โ‚น343.74-16.82%
2023-โ‚น413.26-33.13%
2022-โ‚น617.9560%
2021-โ‚น386.2255.04%
2020-โ‚น249.11207.14%
2019-โ‚น81.11-19.81%
2018-โ‚น101.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น270.99-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น239.46-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA